KRIT1 (O00522) variants and mutations
KRIT1 (also known as O00522) is a human protein-coding gene encoding a krev interaction trapped protein 1 protein. It helps maintain endothelial junctions and vascular integrity as part of the cerebral cavernous malformation signaling complex. Loss-of-function variants cause cerebral cavernous malformation type 1 and predispose to fragile vascular lesions in the brain and spinal cord. This analysis covers 1,128 KRIT1 variants and mutations. Of these, 73% have computational variant effect predictions. Example KRIT1 variants include M1?, M1V, and N3S.
Variant analysis overview
- Gene: KRIT1
- Protein: O00522
- UniProt accession: O00522
- Organism: Homo sapiens
- Variants analyzed: 1128
- Variant scope: all variants
- Completed: 2026-07-28
Variant and mutation evidence
- Variant composition: 902 unspecified-consequence records; 74 synonymous variants; 132 missense variants; 11 frameshift variants; 5 splice-region variants; 2 in-frame deletions; 2 substitution
- Prediction scores: 827 variants have prediction scores (73% of the analyzed set).
Protein structure and variant hotspots
- Protein features: 1 domains.
- Structural context: 588 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, MaveDB, LitVar.
Notable KRIT1 variants
Examples include M1?, M1V, N3S, P4T, E5Q, I7M, I7T, I7V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV56066
- M1V (p.Met1Val), rs1554539120, ClinGen CA368167328, ClinVar RCV000536000, ClinVar RCV000578776, MetaLR 0.55, MetaSVM -0.12, Pathogenic/Likely pathogenic, not provided; Cerebral cavernous malformation
- N3S (p.Asn3Ser), cosmic curated COSV10505
- P4T (p.Pro4Thr), gnomAD rs878871066, REVEL 0.23, CADD 22.20
- E5Q (p.Glu5Gln), ESP rs374117797, ExAC rs374117797, gnomAD rs374117797, REVEL 0.12, CADD 23.30
- I7M (p.Ile7Met), Ensembl rs202176475, REVEL 0.10, CADD 12.00
- I7T (p.Ile7Thr), cosmic curated COSV56061, TOPMed rs1218350640, gnomAD rs1218350640, REVEL 0.14, CADD 18.10
- I7V (p.Ile7Val), gnomAD rs1799805515, REVEL 0.07, CADD 13.00
- E8A (p.Glu8Ala), TOPMed rs1585030516, REVEL 0.31, CADD 25.00, Uncertain significance, Inborn genetic diseases
- D9H (p.Asp9His), cosmic curated COSV56063
- D9Y (p.Asp9Tyr), NCI-TCGA Cosmic COSV5606, REVEL 0.38, CADD 26.80, Variant assessed as somatic; moderate impact.
- A10G (p.Ala10Gly), rs1057518241, ClinGen CA16042734, ClinVar RCV000412729, Ensembl rs1057518241, AlphaMissense 0.27, MetaLR 0.42, Uncertain significance, not specified
- Y11C (p.Tyr11Cys), NCI-TCGA TCGA novel, REVEL 0.47, CADD 26.30, Variant assessed as somatic; moderate impact.
- V12I (p.Val12Ile), TOPMed rs1015584962, gnomAD rs1015584962, REVEL 0.19, CADD 22.60
- V14A (p.Val14Ala), Ensembl rs1585030358, REVEL 0.44, CADD 24.20
- I15T (p.Ile15Thr), cosmic curated COSV56063, REVEL 0.52, CADD 26.00, Uncertain significance, Cerebral cavernous malformation
- I15V (p.Ile15Val), Ensembl rs924507453
- R16C (p.Arg16Cys), rs370360812, ClinGen CA4339491, cosmic curated COSV56060, ClinVar RCV001160244, REVEL 0.56, CADD 32.00, Conflicting interpretations, Angiokeratoma corporis diffusum with arteriovenous fistulas; Inborn genetic dise
- R16H (p.Arg16His), cosmic curated COSV56059, TOPMed rs1313893193, gnomAD rs1313893193, REVEL 0.48, AlphaMissense 0.79, Uncertain significance
- R16P (p.Arg16Pro), rs1313893193, ClinGen CA368167186, ClinVar RCV001305774, ClinVar RCV002291745, AlphaMissense 0.79, MetaLR 0.75, Uncertain significance, not provided; Cerebral cavernous malformation
- P17A (p.Pro17Ala), TOPMed rs1799796311, gnomAD rs1799796311
- P17Q (p.Pro17Gln), Ensembl rs77066620, REVEL 0.61, CADD 26.40
- P17T (p.Pro17Thr), TOPMed rs1799796311, gnomAD rs1799796311, REVEL 0.58, CADD 26.40
- K18E (p.Lys18Glu), gnomAD rs1281022025, REVEL 0.47, CADD 26.90, Uncertain significance, Cerebral cavernous malformation
- A21T (p.Ala21Thr), gnomAD rs1233466287, REVEL 0.18, CADD 18.00
- S22G (p.Ser22Gly), TOPMed rs1799793450, REVEL 0.38, CADD 25.80
- S22I (p.Ser22Ile), NCI-TCGA Cosmic COSV5605, cosmic curated COSV56058, REVEL 0.45, CADD 26.00, Variant assessed as somatic; moderate impact.
- S22N (p.Ser22Asn), ExAC rs746318987, TOPMed rs746318987, gnomAD rs746318987, REVEL 0.22, CADD 23.60
- L23I (p.Leu23Ile), Ensembl rs1563325257, REVEL 0.28, CADD 23.90
- L23R (p.Leu23Arg), rs1799792039, ClinGen CA368167135, ClinVar RCV001198077, Ensembl rs1799792039, AlphaMissense 0.73, MetaLR 0.73, Uncertain significance, Cerebral cavernous malformation
- N24D (p.Asn24Asp), gnomAD rs1310750547, REVEL 0.19, CADD 22.50
- N24H (p.Asn24His), gnomAD rs1310750547, REVEL 0.27, CADD 23.90
- N24S (p.Asn24Ser), TOPMed rs1799790989, REVEL 0.08, CADD 16.70
- S25F (p.Ser25Phe), rs779446044, ClinGen CA4339489, cosmic curated COSV56062, ClinVar RCV002391611, REVEL 0.53, CADD 28.60, Uncertain significance, Inborn genetic diseases; Cerebral cavernous malformation
- R26L (p.Arg26Leu), cosmic curated COSV56066
- R26Q (p.Arg26Gln), rs34358665, ClinGen CA4339488, cosmic curated COSV56059, ClinVar RCV000266475, REVEL 0.16, CADD 20.10, Benign/Likely benign, Angiokeratoma corporis diffusum with arteriovenous fistulas; Cerebral cavernous
- R26W (p.Arg26Trp), cosmic curated COSV56066, 1000Genomes rs570830572, REVEL 0.44, CADD 29.70
- Y28H (p.Tyr28His), ExAC rs754156971, gnomAD rs754156971, REVEL 0.51, CADD 27.20
- R29K (p.Arg29Lys), ESP rs148993606, ExAC rs148993606, TOPMed rs148993606, gnomAD rs148993606, REVEL 0.05, CADD 23.20
- A30G (p.Ala30Gly), TOPMed rs1799787476
- K31M (p.Lys31Met), rs1367968203, ClinGen CA368167047, ClinVar RCV001768739, TOPMed rs1367968203, REVEL 0.58, CADD 27.80, Uncertain significance, not provided
- K31N (p.Lys31Asn), gnomAD rs1433372919
- K31R (p.Lys31Arg), TOPMed rs1367968203, gnomAD rs1367968203, REVEL 0.36, CADD 24.80, Uncertain significance
- S32L (p.Ser32Leu), cosmic curated COSV56066, ExAC rs767430726, TOPMed rs767430726, gnomAD rs767430726, REVEL 0.20, CADD 22.90
- Y33* (p.Tyr33Ter), TOPMed rs1273978810, gnomAD rs1273978810, CADD 26.80
- E34A (p.Glu34Ala), gnomAD rs1159285806, REVEL 0.59, CADD 32.00
- E34D (p.Glu34Asp), Ensembl rs1799781432, REVEL 0.40, CADD 24.00
- L37S (p.Leu37Ser), ExAC rs757766540, gnomAD rs757766540, REVEL 0.55, CADD 27.10
- H38R (p.His38Arg), gnomAD rs1265322620, REVEL 0.08, CADD 18.10
- H38Y (p.His38Tyr), rs2536106527, ClinGen CA368166770, ClinVar RCV002320538, Uncertain significance, Inborn genetic diseases
- E39D (p.Glu39Asp), gnomAD rs1205643727, REVEL 0.48, CADD 23.50
- V40I (p.Val40Ile), TOPMed rs755097554, gnomAD rs755097554, REVEL 0.12, CADD 21.90
- P41A (p.Pro41Ala), TOPMed rs1258414309, gnomAD rs1258414309, REVEL 0.52, CADD 24.00, Uncertain significance, Inborn genetic diseases
- P41S (p.Pro41Ser), TOPMed rs1258414309, gnomAD rs1258414309, REVEL 0.53, CADD 24.70
- I42F (p.Ile42Phe), TOPMed rs1799540757
- I42T (p.Ile42Thr), rs778226731, ClinGen CA4339468, ClinVar RCV001247250, ClinVar RCV004987003, REVEL 0.29, CADD 21.30, Uncertain significance, Cerebral cavernous malformation; Inborn genetic diseases
- G44* (p.Gly44Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G44E (p.Gly44Glu), cosmic curated COSV10887, gnomAD rs1421882812, REVEL 0.66, CADD 25.50
- G44R (p.Gly44Arg), gnomAD rs1413016568, REVEL 0.66, CADD 26.90
- Q45E (p.Gln45Glu), ExAC rs756365172, gnomAD rs756365172, REVEL 0.10, CADD 18.10, Uncertain significance, Inborn genetic diseases
- Q45K (p.Gln45Lys), ExAC rs756365172, gnomAD rs756365172, REVEL 0.12, CADD 17.80
- K46E (p.Lys46Glu), rs138431665, ClinGen CA4339466, ClinVar RCV001158905, ClinVar RCV001158906, REVEL 0.07, CADD 19.70, Uncertain significance, not provided; Inborn genetic diseases; Angiokeratoma corporis diffusum with arte
- K47E (p.Lys47Glu), cosmic curated COSV60667
- K47Q (p.Lys47Gln), ExAC rs767659177, gnomAD rs767659177, REVEL 0.20, CADD 24.00
- K48N (p.Lys48Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R49E (p.Arg49Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R49G (p.Arg49Gly), gnomAD rs1382124919, REVEL 0.39, CADD 26.70
- R49K (p.Arg49Lys), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10038, REVEL 0.19, CADD 23.60, Variant assessed as somatic; moderate impact.
- K50N (p.Lys50Asn), cosmic curated COSV10968, REVEL 0.26, CADD 24.00
- K50R (p.Lys50Arg), gnomAD rs1799533617, REVEL 0.21, CADD 23.60
- K51* (p.Lys51Ter), ExAC rs754979248, gnomAD rs754979248, CADD 37.00
- K51I (p.Lys51Ile), TOPMed rs1799532226, Uncertain significance, Inborn genetic diseases
- K51N (p.Lys51Asn), Ensembl rs1799531802
- L53F (p.Leu53Phe), ExAC rs765145742, gnomAD rs765145742, REVEL 0.48, CADD 17.80
- L53S (p.Leu53Ser), ExAC rs750425590, gnomAD rs750425590, REVEL 0.58, CADD 26.00
- L54F (p.Leu54Phe), cosmic curated COSV60669
- E55K (p.Glu55Lys), cosmic curated COSV99065
- T56A (p.Thr56Ala), ExAC rs761679956, gnomAD rs761679956
- T56M (p.Thr56Met), ExAC rs753631870, TOPMed rs753631870, gnomAD rs753631870, REVEL 0.28, CADD 21.30
- T56R (p.Thr56Arg), ExAC rs753631870, TOPMed rs753631870, gnomAD rs753631870, REVEL 0.38, CADD 22.80
- K57R (p.Lys57Arg), ExAC rs760394812, TOPMed rs760394812, gnomAD rs760394812, REVEL 0.17, CADD 23.00
- L58F (p.Leu58Phe), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10038, Variant assessed as somatic; moderate impact.
- L58P (p.Leu58Pro), gnomAD rs1259089506, REVEL 0.63, CADD 26.80
- Q59* (p.Gln59Ter), gnomAD rs1192358468, CADD 36.00
- Q59R (p.Gln59Arg), TOPMed rs866162290, REVEL 0.17, CADD 21.70
- G60V (p.Gly60Val), ESP rs372556536, TOPMed rs372556536, Uncertain significance, Inborn genetic diseases
- N61I (p.Asn61Ile), rs931432552, ClinGen CA161915310, ClinVar RCV001755181, TOPMed rs931432552, REVEL 0.16, CADD 16.10, Uncertain significance, not provided
- S62G (p.Ser62Gly), TOPMed rs1445762450, gnomAD rs1445762450, REVEL 0.10, CADD 14.80
- E63A (p.Glu63Ala), ExAC rs774985805, TOPMed rs774985805, gnomAD rs774985805, REVEL 0.26, CADD 24.40
- E63D (p.Glu63Asp), gnomAD rs1272213726
- E63K (p.Glu63Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T65A (p.Thr65Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T65R (p.Thr65Arg), cosmic curated COSV60667
- Q66* (p.Gln66Ter), rs771656368, ClinGen CA4339454, ClinVar RCV000624959, ClinVar RCV005601047, CADD 36.00, Pathogenic
- Q66X, rs771656368, Pathogenic
- I68V (p.Ile68Val), Ensembl rs1585022526
- L69* (p.Leu69Ter), rs1799516672, ClinGen CA368165896, ClinVar RCV001382706, Ensembl rs1799516672, AlphaMissense 0.79, MetaLR 0.73, Pathogenic
- L69S (p.Leu69Ser), Ensembl rs1799516672, Pathogenic
- D70G (p.Asp70Gly), TOPMed rs1050501717, gnomAD rs1050501717, REVEL 0.42, CADD 29.30
- V72A (p.Val72Ala), rs1440357472, ClinGen CA368165802, ClinVar RCV002417891, gnomAD rs1440357472, REVEL 0.35, CADD 25.80, Uncertain significance, Inborn genetic diseases
- V72I (p.Val72Ile), cosmic curated COSV60666, ExAC rs775059905, TOPMed rs775059905, gnomAD rs775059905, REVEL 0.14, CADD 21.30
- V73A (p.Val73Ala), ExAC rs771579206, TOPMed rs771579206, gnomAD rs771579206, REVEL 0.07, CADD 21.40
- T75A (p.Thr75Ala), TOPMed rs1799508200, gnomAD rs1799508200, REVEL 0.07, CADD 17.40
- K77R (p.Lys77Arg), rs1799505965, ClinGen CA368165724, ClinVar RCV001158903, ClinVar RCV001158904, AlphaMissense 0.09, MetaLR 0.47, Uncertain significance, Cerebral cavernous malformation; Angiokeratoma corporis diffusum with arterioven
- P78L (p.Pro78Leu), gnomAD rs1370334322
- I79F (p.Ile79Phe), 1000Genomes rs116801031, ESP rs116801031, ExAC rs116801031, TOPMed rs116801031, REVEL 0.28, CADD 23.70, Likely benign
- I79V (p.Ile79Val), rs116801031, ClinGen CA4339447, ClinVar RCV000964766, ClinVar RCV003169482, REVEL 0.06, CADD 18.90, Likely benign, Inborn genetic diseases; Cerebral cavernous malformation
- S80Y (p.Ser80Tyr), cosmic curated COSV10968, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P81A (p.Pro81Ala), TOPMed rs1799503407
- P81L (p.Pro81Leu), ExAC rs781265273, TOPMed rs781265273, gnomAD rs781265273, REVEL 0.29, CADD 27.40
- A82G (p.Ala82Gly), ExAC rs749330621, gnomAD rs749330621, REVEL 0.20, CADD 20.60
- A82T (p.Ala82Thr), rs2536103082, ClinGen CA368165688, ClinVar RCV002748145, Uncertain significance, Inborn genetic diseases
- Q84* (p.Gln84Ter), rs751651833, ClinGen CA4339444, ClinVar RCV001387434, ExAC rs751651833, CADD 37.00, Pathogenic
- Q84L (p.Gln84Leu), TOPMed rs1427367978
- Q84P (p.Gln84Pro), TOPMed rs1427367978, REVEL 0.41, CADD 24.40
- G85D (p.Gly85Asp), TOPMed rs1307060289, gnomAD rs1307060289, REVEL 0.65, CADD 25.60
- I86V (p.Ile86Val), Ensembl rs1585022043, REVEL 0.06, CADD 20.20
- R87G (p.Arg87Gly), Ensembl rs747325378
- R87K (p.Arg87Lys), TOPMed rs1335478074, gnomAD rs1335478074, REVEL 0.07, CADD 14.30, Uncertain significance
- R87T (p.Arg87Thr), TOPMed rs1335478074, gnomAD rs1335478074, REVEL 0.27, CADD 18.60, Uncertain significance, not provided
- G88E (p.Gly88Glu), TOPMed rs899688735, REVEL 0.57, CADD 33.00
- R90* (p.Arg90Ter), rs1563313372, ClinGen CA368164802, ClinVar RCV000721881, ClinVar RCV000803135, CADD 41.00, Pathogenic
- R90Q (p.Arg90Gln), ExAC rs747189196, gnomAD rs747189196, REVEL 0.49, CADD 29.40
- L93P (p.Leu93Pro), TOPMed rs1235381178, gnomAD rs1235381178, REVEL 0.32, CADD 24.60
- M94I (p.Met94Ile), cosmic curated COSV60669
- M94V (p.Met94Val), rs2536059238, ClinVar RCV004560385, REVEL 0.18, CADD 22.90, Uncertain significance, Cerebral cavernous malformation
- K95E (p.Lys95Glu), gnomAD rs1364075807, REVEL 0.25, CADD 24.50
- K96E (p.Lys96Glu), gnomAD rs1180642422, REVEL 0.12, CADD 22.60
- K96T (p.Lys96Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F97C (p.Phe97Cys), NCI-TCGA Cosmic COSV6066, cosmic curated COSV60667, Variant assessed as somatic; moderate impact., in CCM1
- F97I (p.Phe97Ile), cosmic curated COSV10650
- F97S (p.Phe97Ser), UniProt VAR 023573, Pathogenic, in CCM1
- P98S (p.Pro98Ser), rs199905288, ClinGen CA4339421, ClinVar RCV003356305, ClinVar RCV005104071, REVEL 0.10, CADD 22.70, Conflicting interpretations, Inborn genetic diseases; Cerebral cavernous malformation
- L99Q (p.Leu99Gln), rs1445866560, ClinGen CA368164574, ClinVar RCV001061809, gnomAD rs1445866560, REVEL 0.53, CADD 32.00, Uncertain significance, Cerebral cavernous malformation
- L99V (p.Leu99Val), cosmic curated COSV60668, REVEL 0.22, CADD 22.60
- D100A (p.Asp100Ala), TOPMed rs1420680753, gnomAD rs1420680753, REVEL 0.24, CADD 26.80
- D100V (p.Asp100Val), TOPMed rs1420680753, gnomAD rs1420680753
- G101E (p.Gly101Glu), ESP rs147568834, ExAC rs147568834, TOPMed rs147568834, gnomAD rs147568834, Benign
- G101R (p.Gly101Arg), rs1057521140, ClinGen CA16605918, ClinVar RCV000427958, ClinVar RCV002519528, AlphaMissense 0.22, MetaLR 0.70, Conflicting interpretations, not provided; Cerebral cavernous malformation
- G101V (p.Gly101Val), rs147568834, ClinGen CA4339419, ClinVar RCV000265398, ClinVar RCV000320476, REVEL 0.49, CADD 26.70, Conflicting interpretations, not provided; Cerebral cavernous malformation; Angiokeratoma corporis diffusum w
- K103N (p.Lys103Asn), cosmic curated COSV60667
- K103R (p.Lys103Arg), gnomAD rs1329724001, REVEL 0.05, CADD 22.30
- G105C (p.Gly105Cys), ExAC rs755998845, gnomAD rs755998845, REVEL 0.66, CADD 24.30
- G105D (p.Gly105Asp), ESP rs376022532, ExAC rs376022532, TOPMed rs376022532, gnomAD rs376022532, REVEL 0.55, CADD 23.60
- G105V (p.Gly105Val), ESP rs376022532, ExAC rs376022532, TOPMed rs376022532, gnomAD rs376022532, REVEL 0.67, CADD 23.60
- R106G (p.Arg106Gly), ExAC rs754710526, gnomAD rs754710526, REVEL 0.29, CADD 23.70, Uncertain significance, Inborn genetic diseases
- R106K (p.Arg106Lys), NCI-TCGA Cosmic COSV6066, cosmic curated COSV60667, TOPMed rs1798712153, gnomAD rs1798712153, REVEL 0.04, CADD 16.10, Variant assessed as somatic; moderate impact.
- E107K (p.Glu107Lys), TOPMed rs1237112169, gnomAD rs1237112169, REVEL 0.24, CADD 25.50
- A108T (p.Ala108Thr), ExAC rs766038368, gnomAD rs766038368, REVEL 0.34, CADD 21.90
- A108V (p.Ala108Val), TOPMed rs1336315291
- S109P (p.Ser109Pro), cosmic curated COSV10741
- F111L (p.Phe111Leu), ExAC rs765675250, gnomAD rs765675250, REVEL 0.39, CADD 22.70
- F111S (p.Phe111Ser), NCI-TCGA Cosmic COSV6066, cosmic curated COSV60666, Variant assessed as somatic; moderate impact.
- F111V (p.Phe111Val), NCI-TCGA Cosmic COSV6067, cosmic curated COSV60670, Variant assessed as somatic; moderate impact.
- V113I (p.Val113Ile), TOPMed rs1798706139, gnomAD rs1798706139, REVEL 0.42, CADD 25.60
- P114A (p.Pro114Ala), TOPMed rs1447587014, REVEL 0.69, CADD 24.00
- P114L (p.Pro114Leu), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10038, Variant assessed as somatic; moderate impact.
- P114T (p.Pro114Thr), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10038, REVEL 0.76, CADD 27.60, Variant assessed as somatic; moderate impact.
- V116I (p.Val116Ile), ESP rs377033859, ExAC rs377033859, TOPMed rs377033859, gnomAD rs377033859, REVEL 0.05, CADD 20.60
- K118E (p.Lys118Glu), Ensembl rs1798703959
- K118R (p.Lys118Arg), Ensembl rs1798703452
- D119G (p.Asp119Gly), TOPMed rs1469867475, gnomAD rs1469867475, REVEL 0.51, CADD 27.00
- N120S (p.Asn120Ser), gnomAD rs1274117057, REVEL 0.17, CADD 25.00
- T121I (p.Thr121Ile), TOPMed rs1180804711, gnomAD rs1180804711, REVEL 0.07, CADD 22.50
- Y123* (p.Tyr123Ter), cosmic curated COSV60668, CADD 34.00
- Y123C (p.Tyr123Cys), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10038, Variant assessed as somatic; moderate impact.
- T124A (p.Thr124Ala), ExAC rs766114156, TOPMed rs766114156, gnomAD rs766114156, REVEL 0.11, CADD 14.60
- Y125C (p.Tyr125Cys), Ensembl rs1798468453, REVEL 0.54, CADD 29.80
- Y125H (p.Tyr125His), ExAC rs758062997, TOPMed rs758062997, gnomAD rs758062997, REVEL 0.13, CADD 22.70
- Y125N (p.Tyr125Asn), ExAC rs758062997, TOPMed rs758062997, gnomAD rs758062997
- T126N (p.Thr126Asn), TOPMed rs1232504536, gnomAD rs1232504536, REVEL 0.12, CADD 19.20
- T126S (p.Thr126Ser), Ensembl rs1563309884, Uncertain significance, Inborn genetic diseases
- P127L (p.Pro127Leu), NCI-TCGA Cosmic COSV6066, cosmic curated COSV60669, gnomAD rs1216285612, Variant assessed as somatic; moderate impact.
- P127Q (p.Pro127Gln), gnomAD rs1216285612, REVEL 0.53, CADD 24.40
- P127S (p.Pro127Ser), cosmic curated COSV10521
- G128* (p.Gly128Ter), rs2131676374, ClinGen CA368162647, ClinVar RCV001384337, Ensembl rs2131676374, Pathogenic
- G128A (p.Gly128Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- C129R (p.Cys129Arg), Ensembl rs1278724570
- C129Y (p.Cys129Tyr), rs764760437, ClinGen CA4339389, ClinVar RCV002227513, ClinVar RCV005590002, REVEL 0.31, CADD 25.40, Uncertain significance, Inborn genetic diseases; Cerebral cavernous malformation
- P130S (p.Pro130Ser), gnomAD rs776803161, REVEL 0.70, CADD 26.60
Public KRIT1 analysis runs
- KRIT1 analysis run — KRIT1 (1,128 variants) — completed 2026-07-28